Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,285
datasets available to search
ShareScore release 0.9.0
Dataset results
2,285 results for “T-cells”
PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT05380635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00290706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
ClinicalTrials.gov study NCT00416351. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a
ClinicalTrials.gov study NCT01794299. IPD Sharing: NO. Countries: 4. Publications: 0.
A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia
ClinicalTrials.gov study NCT03873493. IPD Sharing: YES. Countries: 9. Publications: 0.
CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery
ClinicalTrials.gov study NCT00925756. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematolog
ClinicalTrials.gov study NCT03849651. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor
ClinicalTrials.gov study NCT01598025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT02136797. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT02676778. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00787527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides
ClinicalTrials.gov study NCT04101331. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma
ClinicalTrials.gov study NCT02567656. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT00364923. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin
ClinicalTrials.gov study NCT05886478. IPD Sharing: YES. Countries: 4. Publications: 0.
Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT01646645. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04217317. IPD Sharing: NO. Countries: 1. Publications: 0.
Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1
ClinicalTrials.gov study NCT03007719. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma
ClinicalTrials.gov study NCT03070964. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma
ClinicalTrials.gov study NCT04362007. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.